Dr Judith Offman is an Epidemiologist in the Cancer Prevention Group mainly focusing on the prevention and early diagnosis of oesophageal cancer. She is currently working on several projects on Barrett’s oesophagus, progression to oesophageal cancer, and the BEST3 trial. Judith is also a member of the steering committee of IMPACT, an international targeted prostate screening study of men at increased prostate cancer risk due to the presence of known pathogenic mutations in BRCA1 and BRCA2 genes. Judith joined the team in 2014 after working on breast cancer screening at the Centre for Cancer Prevention at Queen Mary, University of London.